Opendata, web and dolomites

SAP-Nano

A disruptive technology for vaccines manufacturing based on Self-Assembled Polymeric Nanoparticulate systems

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SAP-Nano project word cloud

Explore the words cloud of the SAP-Nano project. It provides you a very rough idea of what is the project "SAP-Nano" about.

issue    veterinary    launch    manufacturing    easily    cosmetic    clients    submission    move    avoiding    requirement    performed    versatile    detected    664    swine    usa    market    solvents    significantly    perform    nano    first    sap    scalability    time    25    manufacturer    2015    verify    fish    laboratory    techniques    evaluation    model    million    opportunity    thorough    11    point    economic    presented    instrument    billion    encapsulate    nanoparticle    firstly    lower    84    scalable    impossible    nmp    12    marketing    total    strategies    usd    pharmaceutical    score    viability    antigens    inexpensive    vaccines    organic    risks    21    suitable    sme    standard    volatile    bionanoplus    successfully    met    prrsv    costly    patented    plan    business    industry    feasibility    conventional    company    molecules    commercial    industrial    seemed    minimize    ensures    manufacturers    solved    faced    nanotechnology    losses    eur   

Project "SAP-Nano" data sheet

The following table provides information about the project.

Coordinator
BIONANOPLUS SL 

Organization address
address: POLIGONO MOCHOLI, PLAZA CEIN 5
city: NOAIN
postcode: 31110
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.bionanoplus.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2016-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIONANOPLUS SL ES (NOAIN) coordinator 50˙000.00

Map

 Project objective

Bionanoplus detected the major problems faced by many pharmaceutical, veterinary and cosmetic sector manufacturers to develop products using nanotechnology. It seemed impossible and costly to move a product developed in the laboratory to the industrial manufacturing of the product. To solve this issue Bionanoplus has developed and patented a highly versatile and easily scalable technology to encapsulate antigens and other molecules, called SAP-Nano. Bionanoplus has solved the scalability problem of traditional nanoparticle manufacturing methods avoiding the use of volatile organic solvents, thus it ensures an easy and inexpensive production of any scale, which can be performed using standard equipment and techniques. SAP-Nano technology has been successfully implemented with two clients, a fish vaccines manufacturer and a pharmaceutical company. Now Bionanoplus plan to launch his technology in the vaccines manufacturers market, firstly on to the PRRSV vaccines manufacturers market. It was estimated that losses due to PRRSV cost the swine industry EUR 1.5 billion per year in Europe and USD 664 million per year in the USA. SAP-Nano enables the development of unique vaccines, which are significantly more effective than conventional vaccines. Phase 1 of SME Instrument represents an opportunity to get a thorough business plan to minimize risks. The main objective is to perform a feasibility study to verify the economic viability in the vaccines manufacturers market and design a suitable business model, and the commercial, marketing and industrial strategies. The SAP-Nano proposal was presented for the first time to the 25-11-2015 call (NMP-25-2015-1-P) achieving a total score of 12,84. The lower point in the evaluation was Impact (score: 4.21). B has met potential clients in order to know the needs and requirement to develop new vaccines. The business case has also been improved. This new information has been included in this new submission of the proposal.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAP-NANO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAP-NANO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

Volumizer (2018)

A natural, non-surgical, and safe facial filler which treats the root cause of facial ageing.

Read More  

HIL PT System (2017)

Revolutionary, cost effective, spatially efficient, proton therapy system for cancer treatment.

Read More